Catalyst Wire Dossier Catalyst Wire Dossier

XS411CN injection

XS411CN · XellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for XS411CN injection, covering 2025-09-11 to 2025-09-11. Get the full timeline:

Most recent: Clinical Trial Update: The Safety and Tolerability of XS411CN Injection in Treatment of Primary Parkinson's Disease [Phase 1]

See pricing